Viewing data from:

CILOSTAZOL

ANDA

CILOSTAZOL | A077030 | APOTEX INC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 4 NDCs

Highest NADAC/Unit

$0.1250

per ea

Lowest NADAC/Unit

$0.1219

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
50268017715CILOSTAZOL 100 MG TABLET	$0.1250	EA	Generic	—	2026-10-21
60505252201CILOSTAZOL 100 MG TABLET	$0.1250	EA	Generic	—	2026-10-21
50268017615CILOSTAZOL 50 MG TABLET	$0.1219	EA	Generic	—	2026-10-21
60505252101CILOSTAZOL 50 MG TABLET	$0.1219	EA	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$15.85

Highest Price

$20.90

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
42291-0453-60CILOSTAZOL 100MG TAB	$20.36	FSS	AvKare, LLC	06/14/2028
60505-2521-01CILOSTAZOL 50MG TAB	$15.85	FSS	AvKare, LLC	06/14/2028
60505-2522-01CILOSTAZOL 100MG TAB	$20.90	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain7 active DMFs6 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

COHANCE LIFESCIENCES LTDCILOSTAZOL

DMF 431812025

WAVELENGTH ENTERPRISES LTDCILOSTAZOL

DMF 166452003

TAPI NL BVCILOSTAZOL USP

DMF 167222003

ALIVUS LIFE SCIENCES LTDCILOSTAZOL USP

DMF 168762003

DIPHARMA FRANCIS SRLCILOSTAZOL

DMF 170502003

CHONGQING KANGLE PHARMACEUTICAL CO LTDCILOSTAZOL USP (DRUG SUBSTANCE, NON-STERILE)

DMF 224632009

CHONGQING KANGLE PHARMACEUTICAL CO LTDCILOSTAZOL USP

DMF 256662011

SA AJINOMOTO OMNICHEM NVInactiveCILOSTAZOL

DMF 173722004

ALEMBIC PHARMACEUTICALS LTDInactiveCILOSTAZOL

DMF 174752004

UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)InactiveCILOSTAZOL

DMF 179732004

RANBAXY LABORATORIES LTDInactiveCILOSTAZOL DRUG SUBSTANCE

DMF 190762005

IPCA LABORATORIES LTDInactiveCILOSTAZOL USP

DMF 216782008

CHONGQING KANGLE PHARMACEUTICAL CO LTDInactiveCILOSTAZOL DRUG SUBSTANCE NON STERILE

DMF 226432008

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 50MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Dec 10, 2004

No patent or exclusivity listings for this strength.

#002 — 100MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Dec 10, 2004